
‘Target is to stop spread': Screening camps at Delhi's urban slums strengthen fight against TB
She has been suffering from fever for the last few months and coughs excessively. 'There is a persistent cough and fever which doesn't fade away,' she added. Her X-ray showed abnormalities and cavities in her lungs. 'Now, we will send her to the Nehru Nagar centre where her sputum samples will be collected for further evaluation,' explained District TB officer Dr Umesh Kumar.
The village head has lent his office space for a screening camp under the Delhi government's TB programme for free for a month.
A team of doctors, under the National TB Elimination Programme (NTEP), are screening patients with the help of a handheld X-Ray machine and AI software, which identifies abnormalities in the lungs and is said to have minimal radiation exposure.
According to the 2019-2021 National TB Prevalence Survey, Delhi was identified as having the highest TB prevalence in India, with 747 cases per lakh population.
Under the NTEP, Delhi has been conducting screening drives in urban slums and has started the first phase of the programme targeting six high-burden areas — Nehru Nagar, Narela, Karawal Nagar, Moti Nagar, Babu Jagjivan Ram Memorial Hospital's chest clinic and Shastri Nagar.
In Nehru Nagar, five areas have been targeted — Indira Kalyan Vihar, Jaitpur, Pul Prahladpur, Nizamuddin and Batla House.
To drive engagement, doctors and volunteers also conduct door-to-door drives, and announcements are made on loudspeakers as well.
Five X-ray machines have been set up in each camp in the slums of South Delhi. 'The programme has been functioning since last December, and we started again in June this year. Our target is to stop the spread of TB, and we need to do catchment at the mass level. Except pregnant women and children below 15 years, everyone else is being screened,' Dr Umesh explained. Since June, more than 10,000 people have been screened, and around 40 people have been identified as TB affected at such camps across the city, said sources.
Along with the mass-level screening, these camps provide prevention therapy to people who are at high risk — they collect the medicines from the nearby DOT centre, a healthcare facility focused on tuberculosis.
'Before prescribing medicines under TB prevention therapy, we confirm about latent TB infection by the Cy-Tb test, a modern skin test for detecting Mycobacterium tuberculosis infection, a bacterium that causes tuberculosis. If it is positive in TB contact persons, we give them the preventive therapy,' underlined Dr Umesh Kumar.
For this, the doctors deployed are particularly targeting the high-risk group, which includes patients with diabetes, those with alcohol or cigarette addiction, those who are not gaining weight and those who are living in families where someone had TB in the last five years. The camp at Indira Kalyan Vihar Jhuggi has been conducting 150-200 X-rays daily at the centre. Even as 5-10% of X-rays highlight abnormalities on average every day, not all of these patients test positive for TB.
'The X-rays highlight if there is fluid in the lungs, signs of pneumonia, old or new pneumonia and cavities in the lungs. If these abnormalities are found, we send the patient for further tests,' said Dr Umesh.
With the X-ray machines, screening takes just 5-10 minutes, and the visitors can get details added to the system, which is convenient for many. One doctor, one technician and one patient mobiliser and a volunteer for registration of people have been deployed at each camp.
Meanwhile, more women than men are visiting the camp at Indira Kalyan Vihar, according to the team. 'This may be because most of the women are at home, and the men of the house go to work. Which is why we are taking this till 4 pm to target the men as well,' said Himansh Parewa, junior field officer who has been mobilising people from the jhuggi cluster.
'We mobilise the community with the help of ANM and ASHA workers and TB health workers from the Dot centres,' he added.
However, this does not mean more women are testing positive. 'Diabetics, malnourished smokers, those with a family history of TB have the highest prevalence, along with those who are living in poorly ventilated areas, which makes slum areas more at risk,' explained Dr Umesh.
A majority of men in the area, according to Himansh, are factory workers who have to leave for work early morning, due to which it remains a challenge to screen them.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
12 hours ago
- Time of India
Guv aims to make Mizoram India's first TB-free state, urges action
1 2 Aizawl: Mizoram governor Gen Vijay Kumar Singh on Wednesday attended the Pradhan Mantri TB Mukt Bharat Abhiyaan programme at the Raj Bhavan in Aizawl. The event included a felicitation ceremony for Nikshay Mitras — volunteers providing nutritional support to tuberculosis (TB) patients — and distribution of food baskets under the Food Basket Support initiative. In his address, Singh reiterated India's target to eliminate tuberculosis by 2025, five years ahead of the global goal, stressing the urgency of intensified efforts with only six months remaining. He emphasised that success depends on collective action beyond the health department, highlighting improved diagnostics and accessible medicines that have made TB more manageable. Singh commended health officials and volunteers but noted a shortfall in nutritional support — of 1,501 TB patients under treatment in Mizoram, only 117 (7.8%) receive food aid. He pledged personal support for 10 patients and appealed to civil societies, churches and all stakeholders to ensure every patient receives adequate nutrition, aiming to make Mizoram India's first TB-free state. State health minister Lalrinpuii underscored govt initiatives such as free testing, medicines and monthly nutritional aid of Rs 1,000 credited to patients' accounts.


United News of India
18 hours ago
- United News of India
WHO hails Indian study on nutrition's role in TB as global guideline
New Delhi, Aug 6 (UNI) A study conducted by India that demonstrated the positive impact of nutrition on tuberculosis (TB) outcomes has drawn the attention of the World Health Organisation (WHO) which has described it 'as a global guidance on combating the world's most infectious disease.' Led by the Indian Council of Medical Research (ICMR), the study — conducted in Jharkhand — provided the first evidence that offering additional nutrition helps prevent TB cases and reduces mortality in India. 'The findings from India's RATIONS study on the impact of nutrition on TB outcomes and incidence have contributed to global guidance,' the WHO said during a three-day virtual workshop. The study, 'Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India' is published in The Lancet Global Health in 2023. The researchers of the study had provided nutritional support to a cohort with a high prevalence of severe undernutrition in the State. The results were encouraging. 'Weight gain, particularly in the first 2 months, was associated with a substantially decreased hazard of tuberculosis mortality. Nutritional support needs to be an integral component of patient-centred care to improve treatment outcomes in such settings,' said the study. Asserting the member nations to share such innovative practices, the WHO has urged the South-East Asia Region — which accounts for the highest share of TB cases and deaths globally — to also urgently scale up research and innovation to meet End TB goals. 'In our region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023,' said Dr. Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region in a statement here. She further added, 'Achieving the ambitious targets of the WHO End TB Strategy requires collaboration to accelerate research and innovation. This includes adopting and using new tools, technologies, and drugs. Ensuring timely and equitable access to these innovations is critical to achieving impact at scale, leaving no one behind.' The WHO noted that the South-East Asia Region has made notable progress, including a rise in TB case notifications in 2023 — a sign of recovery following COVID-19-related setbacks, however, progress remains insufficient to meet End TB Strategy targets. Following the pandemic, noted the WHO, as per the statement, TB has re-emerged as the world's leading cause of death from a single infectious agent. The disease disproportionately affects the poorest and most vulnerable, deepening existing inequalities. To counter this, 'countries in the region are increasingly leveraging new approaches such as artificial intelligence for case detection, computer-aided diagnostics, digital adherence tools, and direct benefit transfers for patients to streamline social support,' the WHO said. 'Our progress is uneven. Research and innovation capacity varies across the region, and the results of these efforts are often siloed and inaccessible for collaborative use. The rise in drug-resistant TB remains very concerning,' said Boehme. UNI AJ SSP


The Hindu
20 hours ago
- The Hindu
WHO calls for research scale-up towards ending TB in South-East Asia region
The WHO on Tuesday called for urgent scale-up of research, innovation and collaboration to accelerate momentum towards ending tuberculosis in the South-East Asia region, which continues to bear nearly half of the global TB burden, accounting for the highest share of cases and deaths worldwide. Calling for urgent action Experts, national TB programme managers and researchers along with partners and members of civil society began a three-day virtual workshop organised by the World Health Organization (WHO) for advancing research and innovation to accelerate momentum towards ending TB in the WHO South-East Asia region. "In our Region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023," said Dr Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region. Calling for urgent action, she said that achieving the ambitious targets in the WHO End TB Strategy requires collaboration to accelerate research and innovation. It requires the adoption and use of new tools, technologies and drugs. Ensuring timely and equitable access to these innovations remains critical to achieving impacts at scale, leaving no one behind, Boehme said. While the region recorded a significant increase in TB case notifications in 2023, signalling recovery after COVID-19-related setbacks, progress remains insufficient to meet the End TB Strategy targets aligned with the sustainable development goals that call for a 90 per cent reduction in TB deaths and an 80 per cent reduction in incidence by 2030 compared to 2015 levels. Post-COVID-19 pandemic, TB once again reemerged as the world's leading cause of death from a single infectious agent, the WHO said in a statement. It places a disproportionate burden on the poorest and most vulnerable, further exacerbating inequalities. In the South-East Asia region, 30 per cent to 80 per cent of the TB-affected households experience catastrophic costs, underscoring the need for equitable, people-centred approaches and strengthening social protection for the affected, the statement said. New approaches and progress Despite these challenges, the WHO South-East Asia region made notable progress. In 2023, 3.8 million new and relapse TB cases were notified, with an 89 per cent treatment success rate for those who began treatment in 2022. Missed cases dropped to 22 per cent in 2023, down from 44 per cent in 2020, the statement said. Backed by strong political commitment, countries in the region are increasingly leveraging new approaches such as artificial intelligence for case detection, computer-aided diagnostics, digital adherence tools and direct benefit transfers for patients, streamlining the social support process. At the same time, several countries are undertaking important research, including epidemiological research to assess the disease burden, the statement said. Bangladesh recently completed a patient cost survey, while findings from India's RATIONS study on the impact of nutrition on TB outcomes and incidence of the disease have contributed to the global guidance. Social and community-based innovations are also playing a vital role. Nepal's TB-Free Pallika initiative and multisectoral coordination mechanisms in Myanmar are helping reach vulnerable populations with person-centred care. A review by the WHO South-East Asia found that member states published over 3,000 TB-related research articles in the past six years, with 60 per cent being original research. However, uptake of research outcomes remains uneven due to knowledge gaps and limited platforms for knowledge exchange and collaborative use, the statement said. "Our progress is uneven. Research and innovation capacity is varied across the Region, and the results of these efforts are often siloed and unavailable for collaborative use. The rise in drug-resistant forms of TB remains very concerning," said Dr Boehme. Global efforts and vaccine preparedness The key areas of focus during the virtual consultation include strengthening of South-South collaboration, vaccine preparedness, digital tools for patient care and adherence and efforts to overcome vaccine hesitancy. Participants will also discuss aligning regulatory processes, promoting data sharing and improving platforms for knowledge exchange. A significant emphasis is being placed on identifying operational implementation research priorities, especially in relation to social determinants such as undernutrition and climate change, which influence TB incidence and outcomes. "Several ongoing innovations are attempting to reach out to marginalised and vulnerable groups through active case finding and providing affected families socio-economic support to mitigate catastrophic costs", said Dr Boehme. Highlighting the importance of equity, she added, "It is incumbent to ensure equitable access to the benefits of research and innovation, including vaccines, medicines and diagnostics."